CMIIU
Get informed when a big investor buys or sells
+ FollowOvervalued by 119.4% based on the discounted cash flow analysis.
| Market cap | $396.23 Million |
|---|---|
| Enterprise Value | $395.14 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.59 |
| Beta | -0.08 |
| Outstanding Shares | 23,665,000 |
| P/E Ratio | 205.4 |
|---|---|
| PEG | -202.06 |
| Price to Sales | 10.27 |
| Price to Book Ratio | 1.14 |
| Enterprise Value to Revenue | 9.29 |
| Enterprise Value to EBIT | -7.4 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
CM Life Sciences II Inc. is a blank check company formed for the purpose of effecting a business combination. The Company intends to focus its search for business combination targets in three separate areas of the life sciences industry ...